Study in Patients With COPD

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

• Diagnosis of COPD

• History of cigarette smoking

Exclusion Criteria:

• Clinical diagnosis of asthma

• Significant pulmonary disease other than COPD

• Other significant major organ disease(s)